LANGER DENNIS

Director at MYRIAD GENETICS INC · on record since Jan 6, 2006
Director at CYTOGEN CORP · on record since Jun 15, 2006
Director at SIRNA THERAPEUTICS INC · on record since Aug 22, 2006
Director at PHARMACOPEIA DRUG DISCOVERY INC · on record since May 7, 2007
Director at AUXILIUM PHARMACEUTICALS INC · on record since Jul 25, 2007
Director at Myriad Pharmaceuticals, Inc. · on record since Jun 11, 2009
Director at TRANSKARYOTIC THERAPIES INC · on record since Jan 7, 2004
Director at Dicerna Pharmaceuticals Inc · on record since Jan 29, 2014
Director at DELCATH SYSTEMS INC · on record since Dec 15, 2014
Director at GOLF TRUST OF AMERICA INC · on record since Nov 8, 2016
Director at BIOTIME INC · on record since May 5, 2021
Director at Quoin Pharmaceuticals, Ltd. · on record since Mar 7, 2023

Insider trading activity of LANGER DENNIS

Transactions on record: 202; since Jan 7, 2004

Open-market buys: 1; $128.6K

Open-market sells: 37; $10.6M

Companies traded: 12; last filing Feb 6, 2026

Figures computed from official regulatory filings — methodology.

Companies where LANGER DENNIS has traded

Quoin Pharmaceuticals, Ltd.11 tx · $128.9K · Feb 6, 2026
MYRIAD GENETICS INC118 tx · $15.6M · Jun 3, 2022
BIOTIME INC1 tx · Dec 10, 2021
Dicerna Pharmaceuticals Inc30 tx · $847.4K · Jun 21, 2019
GOLF TRUST OF AMERICA INC3 tx · May 23, 2018
DELCATH SYSTEMS INC3 tx · Jun 12, 2015
Myriad Pharmaceuticals, Inc.3 tx · Dec 12, 2011
AUXILIUM PHARMACEUTICALS INC13 tx · $46.1K · Jun 7, 2010
CYTOGEN CORP9 tx · May 9, 2008

Track record of LANGER DENNIS

Statistical track record

Free

Open-market buys: 5

Last buy: Oct 14, 2025

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of LANGER DENNIS

Co-insiders of LANGER DENNIS

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Quoin Pharmaceuticals, Ltd.	Feb 6, 2026	AwardD	21,709	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	Buy	15,152	8.49 USD	$128.6K	SEC
Quoin Pharmaceuticals, Ltd.	Aug 25, 2025	AwardD	13,682	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Jun 2, 2025	AwardD	7,760	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Dec 10, 2024	AwardD	50,714	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Jun 10, 2024	Sell	-297	0.73 USD	$216.8	SEC
Quoin Pharmaceuticals, Ltd.	Oct 30, 2023	AwardD	7,652	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Jun 3, 2022	Award	17,275	0.00 USD	$0	SEC
BIOTIME INC	Dec 10, 2021	AwardD	67,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Aug 5, 2021	ExerciseD	-30,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Aug 5, 2021	Exercise	30,000	25.39 USD	$761.7K	SEC
MYRIAD GENETICS INC	Aug 5, 2021	Sell	-30,000	34.75 USD	$1M	SEC
MYRIAD GENETICS INC	Jun 4, 2021	Award	12,848	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Dec 6, 2019	Award	11,687	0.00 USD	$0	SEC
Dicerna Pharmaceuticals Inc	Jun 21, 2019	AwardD	25,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Nov 30, 2018	Award	9,360	0.00 USD	$0	SEC
Dicerna Pharmaceuticals Inc	Aug 17, 2018	Sell	-14,531	16.00 USD	$232.5K	SEC
Dicerna Pharmaceuticals Inc	Aug 17, 2018	Sell	-23,810	16.00 USD	$381K	SEC
Dicerna Pharmaceuticals Inc	Jun 25, 2018	AwardD	25,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Jun 8, 2018	Sell	-3,096	39.35 USD	$121.8K	SEC
MYRIAD GENETICS INC	Jun 8, 2018	Exercise	13,664	21.29 USD	$290.9K	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Quoin Pharmaceuticals, Ltd.	Feb 6, 2026	AwardD	21,709	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	BuyD	15,152	—	—	SEC
Quoin Pharmaceuticals, Ltd.	Oct 15, 2025	Buy	15,152	8.49 USD	$128.6K	SEC
Quoin Pharmaceuticals, Ltd.	Aug 25, 2025	AwardD	13,682	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Jun 2, 2025	AwardD	7,760	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Dec 10, 2024	AwardD	50,714	0.00 USD	$0	SEC
Quoin Pharmaceuticals, Ltd.	Jun 10, 2024	Sell	-297	0.73 USD	$216.8	SEC
Quoin Pharmaceuticals, Ltd.	Oct 30, 2023	AwardD	7,652	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Jun 3, 2022	Award	17,275	0.00 USD	$0	SEC
BIOTIME INC	Dec 10, 2021	AwardD	67,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Aug 5, 2021	ExerciseD	-30,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Aug 5, 2021	Exercise	30,000	25.39 USD	$761.7K	SEC
MYRIAD GENETICS INC	Aug 5, 2021	Sell	-30,000	34.75 USD	$1M	SEC
MYRIAD GENETICS INC	Jun 4, 2021	Award	12,848	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Dec 6, 2019	Award	11,687	0.00 USD	$0	SEC
Dicerna Pharmaceuticals Inc	Jun 21, 2019	AwardD	25,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Nov 30, 2018	Award	9,360	0.00 USD	$0	SEC
Dicerna Pharmaceuticals Inc	Aug 17, 2018	Sell	-14,531	16.00 USD	$232.5K	SEC
Dicerna Pharmaceuticals Inc	Aug 17, 2018	Sell	-23,810	16.00 USD	$381K	SEC
Dicerna Pharmaceuticals Inc	Jun 25, 2018	AwardD	25,000	0.00 USD	$0	SEC
MYRIAD GENETICS INC	Jun 8, 2018	Sell	-3,096	39.35 USD	$121.8K	SEC
MYRIAD GENETICS INC	Jun 8, 2018	Exercise	13,664	21.29 USD	$290.9K	SEC